Serum-Free Growth Medium Sustains Commitment of Human Articular Chondrocyte through Maintenance of Sox9 Expression

Mara Malpeli, Nadia Randazzo, Ranieri Cancedda, Beatrice Dozin

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Human articular cartilage heals poorly in adults and current surgical procedures do not provide long-term repair. Cell therapy and tissue engineering could become the treatment of choice, but suffer a major limitation as chondrocytes in vitro lose the differentiated phenotype. In vivo, the chondrogenic lineage is specified by transcription factor Sox9. Thus, cell-based therapy could be successful if Sox9 expression and chondrogenic commitment of the expanded cells were preserved. To achieve this goal, we developed a serum-free medium that supports cell proliferation and preserves the differentiation potential. Indeed, expression of Sox9 is maintained when the conventionally used serum is substituted for by this defined supplement. Spontaneous cartilage formation after expansion in serum-free medium is obtained in vitro in a high-density pellet culture and confirmed in vivo in a functional assay in immunodeficient mice. By contrast, cells grown in serum lose the expression of Sox9 and fail to reform cartilage both in vitro and in vivo unless they are rescued by chondrogenic inducers such as transforming growth factor β1 and dexamethasone. Our data emphasize the importance of the microenvironment in modulating commitment, plasticity, and phenotype of chondrocytes, and provide an experimental system to study their physiological or pathological metabolism in a controlled context.

Original languageEnglish
Pages (from-to)145-155
Number of pages11
JournalTissue Engineering
Volume10
Issue number1-2
DOIs
Publication statusPublished - Jan 2004

Fingerprint

Serum-Free Culture Media
Cartilage
Chondrocytes
Joints
Maintenance
Cell- and Tissue-Based Therapy
Growth
Cell Engineering
Phenotype
Transcription factors
Cell proliferation
Articular Cartilage
Transforming Growth Factors
Tissue Engineering
Serum
Tissue engineering
Metabolism
Dexamethasone
Plasticity
Assays

ASJC Scopus subject areas

  • Biophysics
  • Cell Biology

Cite this

Serum-Free Growth Medium Sustains Commitment of Human Articular Chondrocyte through Maintenance of Sox9 Expression. / Malpeli, Mara; Randazzo, Nadia; Cancedda, Ranieri; Dozin, Beatrice.

In: Tissue Engineering, Vol. 10, No. 1-2, 01.2004, p. 145-155.

Research output: Contribution to journalArticle

Malpeli, Mara ; Randazzo, Nadia ; Cancedda, Ranieri ; Dozin, Beatrice. / Serum-Free Growth Medium Sustains Commitment of Human Articular Chondrocyte through Maintenance of Sox9 Expression. In: Tissue Engineering. 2004 ; Vol. 10, No. 1-2. pp. 145-155.
@article{d1205d5f87a44f71b6c8b74bcdbbc04e,
title = "Serum-Free Growth Medium Sustains Commitment of Human Articular Chondrocyte through Maintenance of Sox9 Expression",
abstract = "Human articular cartilage heals poorly in adults and current surgical procedures do not provide long-term repair. Cell therapy and tissue engineering could become the treatment of choice, but suffer a major limitation as chondrocytes in vitro lose the differentiated phenotype. In vivo, the chondrogenic lineage is specified by transcription factor Sox9. Thus, cell-based therapy could be successful if Sox9 expression and chondrogenic commitment of the expanded cells were preserved. To achieve this goal, we developed a serum-free medium that supports cell proliferation and preserves the differentiation potential. Indeed, expression of Sox9 is maintained when the conventionally used serum is substituted for by this defined supplement. Spontaneous cartilage formation after expansion in serum-free medium is obtained in vitro in a high-density pellet culture and confirmed in vivo in a functional assay in immunodeficient mice. By contrast, cells grown in serum lose the expression of Sox9 and fail to reform cartilage both in vitro and in vivo unless they are rescued by chondrogenic inducers such as transforming growth factor β1 and dexamethasone. Our data emphasize the importance of the microenvironment in modulating commitment, plasticity, and phenotype of chondrocytes, and provide an experimental system to study their physiological or pathological metabolism in a controlled context.",
author = "Mara Malpeli and Nadia Randazzo and Ranieri Cancedda and Beatrice Dozin",
year = "2004",
month = "1",
doi = "10.1089/107632704322791790",
language = "English",
volume = "10",
pages = "145--155",
journal = "Tissue Engineering",
issn = "1076-3279",
publisher = "Mary Ann Liebert Inc.",
number = "1-2",

}

TY - JOUR

T1 - Serum-Free Growth Medium Sustains Commitment of Human Articular Chondrocyte through Maintenance of Sox9 Expression

AU - Malpeli, Mara

AU - Randazzo, Nadia

AU - Cancedda, Ranieri

AU - Dozin, Beatrice

PY - 2004/1

Y1 - 2004/1

N2 - Human articular cartilage heals poorly in adults and current surgical procedures do not provide long-term repair. Cell therapy and tissue engineering could become the treatment of choice, but suffer a major limitation as chondrocytes in vitro lose the differentiated phenotype. In vivo, the chondrogenic lineage is specified by transcription factor Sox9. Thus, cell-based therapy could be successful if Sox9 expression and chondrogenic commitment of the expanded cells were preserved. To achieve this goal, we developed a serum-free medium that supports cell proliferation and preserves the differentiation potential. Indeed, expression of Sox9 is maintained when the conventionally used serum is substituted for by this defined supplement. Spontaneous cartilage formation after expansion in serum-free medium is obtained in vitro in a high-density pellet culture and confirmed in vivo in a functional assay in immunodeficient mice. By contrast, cells grown in serum lose the expression of Sox9 and fail to reform cartilage both in vitro and in vivo unless they are rescued by chondrogenic inducers such as transforming growth factor β1 and dexamethasone. Our data emphasize the importance of the microenvironment in modulating commitment, plasticity, and phenotype of chondrocytes, and provide an experimental system to study their physiological or pathological metabolism in a controlled context.

AB - Human articular cartilage heals poorly in adults and current surgical procedures do not provide long-term repair. Cell therapy and tissue engineering could become the treatment of choice, but suffer a major limitation as chondrocytes in vitro lose the differentiated phenotype. In vivo, the chondrogenic lineage is specified by transcription factor Sox9. Thus, cell-based therapy could be successful if Sox9 expression and chondrogenic commitment of the expanded cells were preserved. To achieve this goal, we developed a serum-free medium that supports cell proliferation and preserves the differentiation potential. Indeed, expression of Sox9 is maintained when the conventionally used serum is substituted for by this defined supplement. Spontaneous cartilage formation after expansion in serum-free medium is obtained in vitro in a high-density pellet culture and confirmed in vivo in a functional assay in immunodeficient mice. By contrast, cells grown in serum lose the expression of Sox9 and fail to reform cartilage both in vitro and in vivo unless they are rescued by chondrogenic inducers such as transforming growth factor β1 and dexamethasone. Our data emphasize the importance of the microenvironment in modulating commitment, plasticity, and phenotype of chondrocytes, and provide an experimental system to study their physiological or pathological metabolism in a controlled context.

UR - http://www.scopus.com/inward/record.url?scp=1042266503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1042266503&partnerID=8YFLogxK

U2 - 10.1089/107632704322791790

DO - 10.1089/107632704322791790

M3 - Article

VL - 10

SP - 145

EP - 155

JO - Tissue Engineering

JF - Tissue Engineering

SN - 1076-3279

IS - 1-2

ER -